(Q42946330)

English

Correlation of extreme drug resistant assay results and progression-free survival following intraperitoneal chemotherapy for advanced ovarian cancer

scientific article published on August 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Correlation of extreme drug resistant assay results and progression-free survival following intraperitoneal chemotherapy for advanced ovarian cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

1 reference

based on heuristic

Edward J. Tanner

3

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

author name string

Pant AC

1

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Diaz-Montes T

2

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Ahmad S

4

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Giuntoli RL

5

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Holloway RW

6

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Bristow RE

7

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

publication date

1 August 2010

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Journal of Chemotherapy

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

22

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

270-274

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Intraperitoneal cisplatin and paclitaxel in ovarian cancer.

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2010.22.4.270

21 January 2018

Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer.

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2010.22.4.270

21 January 2018

A meta-analysis of the efficacy of intraperitoneal cisplatin for the front-line treatment of ovarian cancer.

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2010.22.4.270

21 January 2018

Association between in vitro platinum resistance in the EDR assay and clinical outcomes for ovarian cancer patients

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2010.22.4.270

21 January 2018

Conservation of in vitro drug resistance patterns in epithelial ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2010.22.4.270

21 January 2018

Identifiers

10.1179/JOC.2010.22.4.270

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42946330&oldid=1974290407"